| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18804410 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 100 journal articles in the PubMed database | Email to a friend | | |
| Locati LD, Bossi P, Perrone F, et al.
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study. [JOURNAL ARTICLE]
Oral Oncol 2008 Sep 17.
Abstract | Full Citation | Find Related Articles | | Agulnik M, Cohen EW, Cohen RB, et al.
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. [Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural]
J Clin Oncol 2007 Sep 1; 25(25):3978-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ramalingam S, Forster J, Naret C, et al.
Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study. [Journal Article, Research Support, Non-U.S. Gov't]
J Thorac Oncol 2008 Mar; 3(3):258-64.
Abstract | Full Citation | Find Related Articles | | Goncalves A, Esteyries S, Taylor-Smedra B, et al.
A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment. [JOURNAL ARTICLE]
BMC Cancer 2008 Jun 10; 8(1):169.
Abstract | Full Citation | Find Related Articles | | Harding J, Burtness B
Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody. [Journal Article, Review]
Drugs Today (Barc) 2005 Feb; 41(2):107-27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mrhalova M, Plzak J, Betka J, et al.
Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. [Journal Article]
Neoplasma 2005; 52(4):338-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hirsch FR, Herbst RS, Olsen C, et al.
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy. [Journal Article, Research Support, N.I.H., Extramural]
J Clin Oncol 2008 Jul 10; 26(20):3351-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lenz HJ, Van Cutsem E, Khambata-Ford S, et al.
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines. [Clinical Trial, Phase II, Journal Article, Multicenter Study]
J Clin Oncol 2006 Oct 20; 24(30):4914-21.
Abstract | Full Citation | Find Related Articles | | Italiano A, Follana P, Caroli FX, et al.
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors for Which FISH Analysis Does Not Detect an Increase in EGFR Gene Copy Number. [JOURNAL ARTICLE]
Ann Surg Oncol 2007 Nov 7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
